FDA Extends IV Fluid Expiry Dates After Shortage Due to Hurricane Helene

Baxter International said the changes apply to products manufactured before September 2024.

File photograph shows bottles of fluid used for intravenous therapy in the emergency room of a hospital in Marseille, France, on Jan. 11, 2017. Boris Horvat/AFP via Getty Images

Baxter International, the leading supplier of intravenous (IV) solutions to hospitals in the United States, said on Oct. 28 that it received approval from the Food and Drug Administration (FDA) to extend the expiry dates of its products.

Baxter temporarily shut down its North Cove manufacturing plant in North Carolina on Sept. 29 due to the impact of Hurricane Helene, which led to a shortage in the supply of IV fluids.